Encephalitis With Antibodies Against the GABAB Receptor: High Mortality and Risk Factors
Encephalitis With Antibodies Against the GABAB Receptor: High Mortality and Risk Factors
复制标题
GABA(B) 受体抗体引起的脑炎:高死亡率和危险因素
DOI:
10.3389/fneur.2019.01030
复制
发表时间:
2019-09-26
影响因子:
3.4
通讯作者:
Hong, Zhen
中科院分区:
文献类型:
--
作者:
Lin, Jingfang;Li, Chen;Hong, Zhen
Objective: To measure mortality, identify predictors of death and investigate causes of death in patients with anti-gamma-aminobutyric-acid B receptor (anti-GABA(B)R) encephalitis.Methods: Prospective analysis of anti-GABA(B)R encephalitis cases diagnosed between June 2013 and August 2018 in West China Hospital of Sichuan University, with assessment of factors associated with mortality.Results: A total of 28 patients (11 females) with anti-GABA(B)R encephalitis were included in this study. After a maximum time of 52 months (median 11 months, range 2-52) of follow-up, 9 (32.1%) patients died, with a median survival time of 6.5 months. Five patients died of tumor progression, one patient died of convulsive status epilepticus, one patient died of septic shock, and two patients died of severe pneumonia. Predictors of death were older age at onset (P = 0.025), presence of a tumor (66.7 vs. 15.8%, P = 0.013), the number of complications (2.6 vs. 1.0, P = 0.009) and deep venous thrombosis (33.3% vs. 0, P = 0.026).Conclusion: Patients with GABA(B)R encephalitis have a high mortality rate within 5 years. Older age at onset, presence a tumor, the number of complications, and deep venous thrombosis are associated with death.